parthenolide and Nasopharyngeal Carcinoma

parthenolide has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HF; Gao, YF; He, CY; Hou, MJ; Huang, YJ; Li, XJ; Liao, K; Lin, YC; Lin, ZN; Ling, WH; Luo, B; Qiu, Y; Xia, B; Zhang, YJ; Zhuang, QY	1

Other Studies

1 other study(ies) available for parthenolide and Nasopharyngeal Carcinoma

Article	Year
Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway. Theranostics, 2015, Volume: 5, Issue:3 Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Gene Expression Profiling; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; NF-kappa B; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction	2015

Article

Year

Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.

Theranostics, 2015, Volume: 5, Issue:3

Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Gene Expression Profiling; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; NF-kappa B; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction

2015